RecruitingNCT06375538

Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy


Sponsor

Shanghai Zhongshan Hospital

Enrollment

200 participants

Start Date

Oct 21, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to predict the failure of High-flow Nasal Cannula oxygenation therapy by ultrasound evaluation of diaphragm and intercostal muscle contraction during the first 24 hours.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • more than 18 years old
  • needing High-flow Nasal Cannula oxygenation therapy

Exclusion Criteria6

  • received mechanical ventilation, including invasive or noninvasive ventilation within one month prior to enrollment
  • history of neuromuscular disorders (e.g., myasthenia gravis, Guillain-Barre syndrome);
  • immediate endotracheal intubation is required (life-threatening hypoxemia)
  • extensive damage to the thoracic skin (e.g., burns) unable to undergo ultrasonography
  • pregnancy
  • attending physician deemed it inappropriate to participate in the trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shanghai Zhongshan Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06375538


Related Trials